InspireMD, Inc. (NSPR)

Market Cap	80.16M
Revenue (ttm)	7.01M
Net Income (ttm)	-32.01M
Shares Out	29.69M
EPS (ttm)	-0.76
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	179,910
Open	2.623
Previous Close	2.700
Day's Range	2.640 - 2.700
52-Week Range	1.810 - 3.800
Beta	0.88
Analysts	Strong Buy
Price Target	4.75 (+75.93%)
Earnings Date	Mar 12, 2025

About NSPR

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem le...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 86
• Stock Exchange: NASDAQ
• Ticker Symbol: NSPR
• Website: https://www.inspiremd.com

Financial Performance

In 2024, InspireMD's revenue was $7.01 million, an increase of 12.96% compared to the previous year's $6.21 million. Losses were -$32.01 million, 60.7% more than in 2023.

Analyst Forecast

According to 2 analysts, the average rating for NSPR stock is "Strong Buy." The 12-month stock price forecast is $4.75, which is an increase of 75.93% from the latest price.

Price Target

$4.75

(75.93% upside)

Analyst Consensus: Strong Buy